References
- Branch DW, Scott JR, Kochenour NK, et al. Obstetric complications associated with the lupus anticoaulant. N Engl J Med 1985; 313:1322–7.
- Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in habitual aborters, normal women and in women who have never been pregnant. Arthritis Rheum 1991; 34:1231–5.
- Branch DW, Silver RM. Criteria for Phospholipid Syndrome: early pregnancy loss, fetal loss or recurrent pregnancy loss. Lupus 1996; 5:409–13.
- Lie JT. Pathology of the Antiphospholipid Syndrome. The antiphospholipid Syndrome, Asherson RA et al. CRC Press 1996; 89–107.
- Salafia CM, Parke AL. Placental pathology in SLE and phospholipid antibody syndrome. Rheum Dis Clinics of N America 1997; 23:85–97.
- Asherson RA, Cervera R. Primary, Secondary and other variants of the Antiphospholipid Syndrome. Lupus 1994; 3:293–8.
- Lubbe WF, Butler WS, Palmer SJ, et al. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983; i:1361–3.
- Parke A, Maier D, Hakim C, Randolph J, Andreoli J. Subclinical autoimmune disease and recurrent spontaneous abortion. J Rheumatol 1986; 13:1178–80.
- McVerry BA, Spearing R, Smith A. SLE anticoagulant: transient inhibition by high dose immunoglobulin infusions. Br J Haematol 1985; 61:579–80.
- Ballow M, Parke A. The uses of intravenous immune globulin in collagen vascular disorders. J Allergy Clin Immunol 1989; 84:608–12.
- Krause I, Blank M, Kopolovic J, et al. Abrogation of experimental SLE and primary antiphospholipid syndrome with IVIG. J Rheumatol 1995; 22:1068–74.